The primary difference is the approved indication,, Ozempic for diabetes, Wegovy for weight management, and the dosing
Whats the Buzz The Bee Healthy Blog Direct-to-Employer GLP-1 Access: What Employers Need to Know Direct-to-employer GLP-1 access allows employers to bypass traditional PBMs, improving pricing transparency, cost predictability, and employee access to evidence-based obesity and chronic disease treatments
On one side, pharmaceutical companies are pushing GLP-1 receptor agonists like semaglutide as the only solution for obesity
doi:10.1016/j.thromres.2020.03.003 59
Information from another book, L'Astronautique (1950) by French Professor Alexandre Ananoff, helped Herg to create his Moon rocket
Nausea is a common side effect, reported in a significant proportion of users in the COR clinical trial programme, and is thought to relate primarily to the bupropion component